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ABSTRACT 
Background: Acute liver failure (ALF) is characterized haemodynamically by a progressive hyperdynamic 
circulation. The pathophysiological mechanism is unknown, but impaired contractility of vascular smooth muscle 
may play an important role. The aim of this study was to evaluate the vascular response to stimulation with 
norepinephrine and angiotensin II in endothelium‐denuded femoral artery rings. Methods: Norwegian Landrace 
pigs weighing 27.1 ± 0.5 kg (mean ± s x (standard error of the mean)) were used. ALF was induced by performing a 
portacaval shunt followed by ligation of the hepatic arteries (n = 6). Sham‐operated animals served as controls (n  = 
5). Cumulative isometric concentration contraction curves were obtained after in vitro stimulation of the femoral 
artery rings with either angiotensin II (10 −13 –10 −5 mol/L) or norepinephrine (10 −13 –10 −3 mol/L). Results: Pigs 
suffering from ALF developed a hyperdynamic circulation with an increased cardiac index (P = 0.017) and decreased 
systemic vascular resistance index (P  = 0.015). Studies of the hind leg revealed a decreased vascular resistance 
index and increased blood flow compared to sham‐operated controls (P = 0.003 and P = 0.01, respectively). 
Angiotensin II caused a concentration‐dependent contraction of the arterial segments, with no significant differences 
in vascular responses between the two groups. Maximum force generated did not differ (55 ± 7 versus 56 ± 7 mN, P 
= 0.95). Furthermore, there were no differences for norepinephrine in the cumulative concentration–response 
curves and the maximum contractile force was not significantly different (87 ± 8 versus 93 ± 16 mN, P = 0.55). 
Conclusions: This study documents for the first time that there are no signs of endothelium‐independent peripheral 
vascular hyporesponsiveness to angiotensin II and norepinephrine in pigs with ALF. 
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Introduction 
Patients suffering from acute liver failure (ALF) develop a hyperdynamic circulation (1). Although the occurrence of 
arterial hypotension is widely recognized (2), the exact pathogenesis has still to be defined. Compensatory activation 
of neurohumoral reflexes involving the sympathetic nervous system and renin-angiotensin axis normally counteract 
for the loss of vascular tone (3). However, despite increased catecholamine levels in plasma, patients remain 
hypotensive with high cardiac output and low systemic vascular resistance (4). Interventions to increase blood 
pressure are often necessary and catecholamines (e.g. epinephrine, norepinephrine and dopamine) are frequently 
given intravenously (5, 6). 
We formerly established a large animal (porcine) model of ALF, induced by hepatic devascularization, which is 
characterized by a sharp increase in serum bilirubin and amino-transferases, coagulopathy, intracranial 
hypertension and a hyperdynamic circulation (7). In this model we found a significant increased blood flow to the 
hind leg and a decreased hind leg vascular resistance as the hyperdynamic circulation progressed, which is not 
Ytrebø, L.M. et al., 2004. Contractile response of femoral arteries in pigs with acute liver failure. Scandinavian journal 
of gastroenterology, 39(10), p.1000–1004. 
The final publication is available at http://dx.doi.org/10.1080/00365520410003254 
considered as an adequate physiologic response to the decline in mean arterial blood pressure (MAP). To date, 
neither animal nor human studies have explored the pathophysiology behind this phenomenon. Two human studies 
have demonstrated increased circulating levels of nitric oxide (NO) in ALF (8, 9). Furthermore, nitric oxide synthase 
(NOS) seems to be upregulated in the hepatic arteries of ALF patients (10). Accordingly, excessive release of NO 
appears to be an important endothelium-dependent pathogenetic factor for the haemodynamic derangement 
observed. However, impaired contractility of vascular smooth muscle tone (endothelium independent) might play a 
significant role as well, though there are no studies that specifically have addressed this issue. Therefore, we decided 
to use our porcine model to investigate the peripheral vascular response to important vasoconstrictors in ALF. 
We hypothesized that arterial hypotension in ALF might be caused partly by a vascular hyporesponsiveness to 
vasoconstrictors. Thus the aim of this study was to investigate the in vitro vascular response to angiotensin II and 
norepinephrine in denuded femoral artery rings (thus excluding interference from endothelium-derived vasoactive 
factors) in a porcine model of ALF (7) and in sham-operated controls. 
METHODS 
The study was performed with the approval of the Norwegian Experimental Animal Board. Eleven Norwegian female 
Landrace pigs, weighing 27.1 ±0.5 kg (mean± sx (standard error of the mean)) were used. Details regarding the 
animal room and preparation of the animals have been published elsewhere (11). The animals were randomized into 
ALF or sham surgery groups by drawing lots before the laparatomy. ALF was induced by performing a portacaval 
shunt followed by ligation of the hepatic arteries (n = 6). Sham-operated animals served as controls (n = 5). The 
surgical procedure has been described elsewhere (12). Briefly, MAP and heart rate were measured by introducing a 
Portex polyethylene tubing (ID 0.58 mm, OD 0.96 mm, Portex Ltd., Hythe, Kent, UK) into the abdominal aorta. A 5 
French Edwards Swan-Ganz catheter (Baxter Healthcare Corp, Irvine, Calif., USA) was floated into the pulmonary 
artery via the right external jugular vein to measure cardiac index (CI) using the thermodilution technique. A 
perivascular, ultrasonic, transit time flow probe (CardioMed Systems, Medistim A/S, Oslo, Norway) was placed 
around the right iliac artery for blood flow measure-ments. Systemic vascular resistance index (SVRI) was calculated 
as: (MAP-CVP)/CI. Hind-leg resistance was calculated as (MAP-CVP)/iliac artery flow. 
Preparation of the vessels 
The experiments were terminated after 6 h, and an incision was made medially on the right leg where the right 
femoral artery was dissected free. The artery was clamped and immediately transferred into oxygenized (95% O2, 
5% CO2) modified ice-cold Krebs-Henseleit solution (in mmol/L: NaCl 118.3, KCl 4.7, CaCl22.5, MgSO41.17, 
KH2PO21.18, NaHCO325.0, EDTA 0.026, glucose 11.1). The vessels were cleaned of connective tissue under a 
magnifying glass and the endothelium was removed mechanically by gently rubbing with a rough steel rod. The 
vessels were cut into 2-mm-wide rings and mounted in an organ bath filled with modified Krebs-Henseleit solution, 
which was continuously exchanged with oxygenized (95% O2, 5% CO2) modified Krebs-Henseleit buffer via a 
syringe pump. Temperature was maintained at 37°C by using an outer water jacket. The vasoconstriction was 
measured with an isometric force transducer (Fort 10; World Precision Instruments, Berlin, Germany). Transducer 
outputs were amplified (Gould Inc., Recording System, Cleveland, Ohio, USA) and recorded electronically using a 
LabVIEW program that was developed in-house (Danielsen, Arild, arildd@fagmed.uit.no). During an equilibration 
period of 1 h, a baseline tension of 20 mN was adjusted. Acetylcholine (10-5mol/ L) was added to prove the absence 
of intact endothelium. In order to ensure viability of the vessels, 40 mmol/L KCl was perfused through the organ 
bath at the end of the experimental period. 
Vascular response to stimulation with angiotensin II and norepinephrine 
The contractile response to angiotensin II and norepinephrine was assessed in the denuded femoral artery rings 
obtained from 11 pigs (6 ALF, 5 sham). The drugs were dissolved in oxygenized modified Krebs-Henseleit buffer and 
added via a syringe pump to the organ bath at a constant infusion rate of 120 mL h -1. 
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Cumulative concentration–response curves for angiotensin II (10 -13 to 10-5 mol/L) and norepinephrine (10 -13 to 10-3 
mol/L) were plotted. The concentration ranges were identified as appropriate from previous pilot experiments and 
in accordance with concentrations applied to human hepatic arteries (13). Contraction force was monitored 
continuously and maximum force was noted within 10 min. These readings were used to plot a cumulative dose–
response curve. No force adjustments were made between the different concentrations. Norepinephrine and 
angiotensin II were purchased from Sigma-Aldrich (Oslo, Norway). 
Determination of urinary norepinephrine 
Analysis of norepinephrine in urine was performed as previously described by Kushnir et al. (14). Urinary 
norepinephrine excretion was calculated as (norepinephrine)urine output. 
Statistical analysis 
Data are presented as the mean ±sx . Vasoconstriction is expressed in milli Newton (mN). The unpaired Student’s t 
test was applied to test for differences in maximum force generated by the vessels. Two-way (group and time) 
analysis of variance for repeated measures was applied for other haemodynamic and biochemical variables. PG 
denotes the effect of group and PGT denotes the interaction for group and time. The unpaired Student’s t test was 
applied to test for differences in haemodynamic and biochemical variables at t = 6 h. A P value 0.05 was taken to 
determine statistical significance. Statistical analyses were performed with the SPSS 11.0 software package (SPSS, 
Chicago, Ill.) and Excel 5.0 (Microsoft). 
RESULTS 
Cardiovascular changes 
The cardiovascular changes are summarized in Table I. Pigs with ALF developed evidence of a hyperdynamic 
circulation with increasing CI and decreasing SVRI. Furthermore, there was a significant difference in iliac artery 
flow between the groups, and a highly significant decrease in hindleg resistance compared with that in sham-
operated controls. Despite a slightly decreased MAP in the sham group during the experimental period, MAP was 
significantly lower in the ALF group t = 6 h. 
Biochemical changes 
Pigs with ALF developed hyperbilirubinaemia. Creatinine levels increased in the ALF group, which caused a significant 
group effect (Table II). There was no significant interaction for norepinephrine excretion in urine, but the ALF group 
tended to have higher norepinephrine levels over the time period studied (PG = 0.056). However, norepinephrine 
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In vitro vascular response 
Acetylcholine & KCl. Endothelial denudation was con-firmed by adding acetylcholine to the organ bath after a 
stabilization period of 1 h. No vascular relaxation was observed. Intact vascular viability was tested before 
termination of the experiments by adding 40 mmol/L KCl to the organ bath. All vessels were viable with a significant 
increase in the contraction force after stimulation (data here as mean± sx for each group). 
Angiotensin II. Stimulation with angiotensin II caused a concentration-dependent contraction of the arterial 
segments. There were no differences in vascular responses between the two vessel groups (Fig. 1). The contractile 
response to ≥10 -5 mol/L angiotensin II was less than that for 10 -7 mol/L, which complies with a plateau phase in the 
contractile response. Maximum force generated after stimulation with angiotensin II did not differ between the ALF 
and control groups (55± 7 and 56 ±7 mN, respectively, P = 0.95) (Fig. 2). A plateau effect was observed at 
concentrations 10 5 mol/L. 
Norepinephrine. There was no significant difference between the groups for norepinephrine 10 3 mol/L. Maxi-mum 
force generated after stimulation with norepinephrine did not differ between the two vessel groups (87± 8 and 93 






Fig. 1. Cumulative concentration–response curves to angiotensin II in isolated, endothelium-denuded femoral artery 
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rings of pigs with acute liver failure (ALF) and sham-operated controls. Contraction forces are expressed in milli 








Fig. 2. Cumulative concentration–response curves to norepinephrine in isolated, endothelium-denuded femoral 
artery rings of pigs with acute liver failure (ALF) and sham-operated controls. Contraction forces are expressed in 
milli Newton as the mean± sx (standard error of the mean). Controls; ALF. 
DISCUSSION 
We investigated the vascular response to angiotensin II and norepinephrine in denuded femoral arteries from pigs 
with ALF. Our results show that neither the maximal contraction force nor the dose–response curves differed 
between pigs with ALF and sham-operated controls. Accordingly, we found no evidence for peripheral vascular 
hyporesponsiveness to these vasoconstrictor neurohormones in ALF. 
The arterial hyporesponsiveness observed in other studies in liver failure may result either from the presence of 
excessive vasorelaxing factors or an impairment of the contractile apparatus of the vascular smooth muscle cells. 
However, a combination of these mechanisms is suggested. Smith et al. found impaired vascular response to 
phenylephrine in hepatic arteries from ALF patients (10), but this was not confirmed in a recently published human 
study of omental arteries (15). Since both phenylephrine and norepinephrine act via the 1-receptors, we assume that 
our results are comparable and a difference (if any) would have been detectable over the concentration and time 
range investigated. Smith et al. performed their study on intact hepatic artery rings, but they were unable to 
demonstrate any relaxation to stimulation with acetylcholine, which implies a lack of endothelium. Therefore, the 
differences in the results from our study and those of Smith et al. are likely to reflect differences in the 
responsiveness of vessels obtained from different vascular beds. 
Peripheral vascular response to angiotensin II has not previously been described either in experimental nor in 
human ALF, but Schepke et al. demonstrated vascular hypo-responsiveness to angiotensin II in hepatic arteries in 
humans with cirrhosis (13). This finding has recently been confirmed in a study of patients with cirrhosis, where 
hyporesponsiveness to angiotensin II was demonstrated in the forearm, but this hyporesponsiveness was corrected 
following inhibition of NOS, suggesting that this hyporesponsiveness is principally due to enhanced NO generation 
(16). 
Our porcine ALF model exhibited a hyperdynamic circulation with increasing cardiac output and decreasing 
systemic vascular resistance during the first 6 h after ALF induction, which is a valid model for the purpose of 
investigating vascular function in ALF. The present data document a peripheral vascular dilatation in the ALF group 
compared to sham-operated controls, which is in accordance with our previously published data (7). Furthermore, 
these animals were rapidly deteriorating with increasing plasma bilirubin levels, along with increasing serum 
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creatinine levels. Urinary norepinephrine excretion was measured to monitor the amounts of circulating endogenous 
norepinephrine levels in the animals. The Data confirm our presumption that ALF pigs do have increased 
catecholamine levels, though still too inadequate to increase MAP. 
Our data show a highly significant decrease in both systemic and regional (hind leg) vascular resistance during the 6-
h experimental period after ALF induction. Furthermore, our data suggest a normal response to important vascular 
smooth muscle constrictors. Accordingly, the peripheral vasodilation in our model seems not to be due to 
hyporesponsiveness to norepinephrine or angiotensin II. However, our results are based on in vitro experiments on 
the femoral arteries and it is impossible to conclude from these experiments what the vascular responses might be in 
other vascular beds.  It remains unknown whether smaller resistance arterioles from the hind leg or vessels from 
other vascular beds exhibit a similar pattern upon stimulation with angiotensin and norepinephrine. These results, 
however, pave the way for further studies of the pathophysiological basis for the circulatory collapse in ALF. First, 
assessment of vascular responsiveness should be further examined in vessels obtained from different vascular beds 
in ALF. Secondly, the impact of endothelium-derived vasodilators such as NO and prostaglandins on vascular 
function need to be further investigated. NOS is up-regulated in hepatic arteries and increased levels of NO have 
been demonstrated in humans with ALF (8, 9). Moreover, prostaglandins are widely known to play an important role 
in the autoregulation of vasogenic tone.  Inducible  cyclooxygenase  (COX-2)  was  recently demonstrated to be up-
regulated in omental arteries harvested from ALF patients, and selective inhibition of COX-2 had a significant  
influence  on  both  norepinephrine  and  thromboxane A2-elicited vasoconstriction in vitro (15). However, the latter 
study, which was performed on splanchnic vessels, does not necessarily reflect the situation in peripheral vessels. In 
conclusion, this study documents for the first time that there is no evidence of peripheral vascular 
hyporesponsiveness of endothelium-denuded vessels to angiotensin II and norepinephrine in pigs with ALF. 
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